Equillium, Inc. financial data

Symbol
EQ on Nasdaq
Industry
Pharmaceutical Preparations
Location
2223 Avenida De La Playa, Suite 105, La Jolla, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 207 % -6.01%
Debt-to-equity 92 % -32%
Return On Equity -52 % -77.6%
Return On Assets -27.1 % -118%
Operating Margin -14.7 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 35.4M shares +0.89%
Common Stock, Shares, Outstanding 35.4M shares +0.87%
Entity Public Float 16M USD -62.9%
Common Stock, Value, Issued 3K USD 0%
Weighted Average Number of Shares Outstanding, Basic 35.4M shares +1.57%
Weighted Average Number of Shares Outstanding, Diluted 35.4M shares +1.57%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 45.9M USD +37.1%
General and Administrative Expense 13.4M USD -13.8%
Operating Income (Loss) -6.77M USD +27%
Nonoperating Income (Expense) 57K USD -75%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -11.6M USD +59.8%
Income Tax Expense (Benefit) 16K USD -97.2%
Net Income (Loss) Attributable to Parent -11.6M USD -41.2%
Earnings Per Share, Basic -0.13 USD/shares +31.6%
Earnings Per Share, Diluted -0.13 USD/shares +31.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 15.4M USD -55.1%
Cash, Cash Equivalents, and Short-term Investments 25.9M USD -44.1%
Accounts Receivable, after Allowance for Credit Loss, Current 5.01M USD +32.9%
Other Assets, Current 381K USD
Assets, Current 33.6M USD -37.6%
Property, Plant and Equipment, Net 293K USD -6.39%
Operating Lease, Right-of-Use Asset 473K USD -48.7%
Other Assets, Noncurrent 45K USD -43%
Assets 34.5M USD -37.6%
Accounts Payable, Current 3.67M USD +0.85%
Employee-related Liabilities, Current 2.56M USD +8.35%
Accrued Liabilities, Current 5.05M USD -39.2%
Liabilities, Current 11.1M USD -60.8%
Operating Lease, Liability, Noncurrent 223K USD -55.2%
Liabilities 11.3M USD -63.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3K USD -101%
Retained Earnings (Accumulated Deficit) -188M USD -2.52%
Stockholders' Equity Attributable to Parent 23.2M USD -3.86%
Liabilities and Equity 34.5M USD -37.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.8M USD -10.1%
Net Cash Provided by (Used in) Financing Activities -1.43M USD
Net Cash Provided by (Used in) Investing Activities -2.83M USD +88.8%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 35.4M shares +0.87%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -11.6M USD +66.3%
Deferred Tax Assets, Valuation Allowance 47.2M USD +1.93%
Deferred Tax Assets, Gross 47.4M USD -0.38%
Operating Lease, Liability 497K USD -46.3%
Depreciation 32K USD +3.23%
Payments to Acquire Property, Plant, and Equipment 19K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -5.08M USD +36.2%
Lessee, Operating Lease, Liability, to be Paid 539K USD -47.6%
Operating Lease, Liability, Current 274K USD -36%
Lessee, Operating Lease, Liability, to be Paid, Year Two 169K USD -22.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 219K USD -55.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 42K USD -58.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 28K USD -83.4%
Deferred Tax Assets, Operating Loss Carryforwards 19.6M USD -30.7%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 6.08M USD +3.33%
Lessee, Operating Lease, Liability, to be Paid, Year Four 28K USD -83.4%
Operating Lease, Payments 122K USD -26.9%
Deferred Tax Assets, Net of Valuation Allowance 228K USD -82.5%
Share-based Payment Arrangement, Expense 3.98M USD -0.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%